Growth Metrics

Vericel (VCEL) Equity Average: 2011-2025

Historic Equity Average for Vericel (VCEL) over the last 14 years, with Sep 2025 value amounting to $314.3 million.

  • Vericel's Equity Average rose 25.62% to $314.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $314.3 million, marking a year-over-year increase of 25.62%. This contributed to the annual value of $259.0 million for FY2024, which is 23.84% up from last year.
  • According to the latest figures from Q3 2025, Vericel's Equity Average is $314.3 million, which was up 4.38% from $301.1 million recorded in Q2 2025.
  • Vericel's Equity Average's 5-year high stood at $314.3 million during Q3 2025, with a 5-year trough of $137.2 million in Q1 2021.
  • Over the past 3 years, Vericel's median Equity Average value was $238.4 million (recorded in 2024), while the average stood at $246.3 million.
  • Data for Vericel's Equity Average shows a peak YoY spiked of 38.54% (in 2021) over the last 5 years.
  • Vericel's Equity Average (Quarterly) stood at $163.6 million in 2021, then grew by 13.10% to $185.1 million in 2022, then increased by 16.27% to $215.2 million in 2023, then increased by 27.68% to $274.7 million in 2024, then grew by 25.62% to $314.3 million in 2025.
  • Its Equity Average stands at $314.3 million for Q3 2025, versus $301.1 million for Q2 2025 and $293.7 million for Q1 2025.